OphSourceHomeJournal CollectionOphSource ShopEvents
Journal Home
Search for

Volume 111, Issue 5, Pages 992-996 (May 2004)


View previous. 9 of 42 View next.

Chorioretinal scar growth after 810-nanometer laser treatment for retinoblastoma

Thomas C Lee, MD2, Sang-Woo Lee, MD2, Marc J Dinkin, MD2, Michael D Ober, MD2, Katherine L Beaverson, MS1, David H Abramson, MD1Corresponding Author Informationemail address

Received 18 March 2003; accepted 22 August 2003.

Abstract 

Purpose

To determine the extent of expansion of laser scars after single treatment with transpupillary thermotherapy (TTT) for retinoblastoma.

Design

We retrospectively reviewed medical records and RetCam (Massie Industries, Dublin, CA) digital fundus photographs of patients with retinoblastoma who received TTT by use of an 810-nm diode laser with large-spot indirect ophthalmoscope. Digital images were measured by use of RetCam software beginning immediately after treatment. Lesions were measured in both linear size and area by 2 observers. In addition, optic disc diameters were also measured for each image.

Participants

We identified 9 patients with hereditary retinoblastoma who were treated from 1997 to 2000.

Main outcome measures

Linear and area expansion of laser scars as a function of time.

Results

Fourteen tumors in 10 eyes were treated successfully with 1 session of TTT. Follow-up for all eyes was at least 16 months. Scars of 12 of the 14 lesions increased beyond their original borders (mean starting linear diameter, 2.02 mm; range 1.46–2.59 mm; mean increase, 0.72 mm [36%]) over time, most within 6 months to 1 year after treatment.

Conclusions

Scars from TTT for retinoblastoma may increase in size after treatment. This expansion must be considered when applying TTT to tumors near vital macular structures, such as the fovea and optic nerve.

1 Ophthalmic Oncology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York, USA

2 Department of Ophthalmology, Robert M. Ellsworth Ocular Oncology Center, New York–Presbyterian Hospital, Weill Medical College, Cornell University, New York, New York, USA

Corresponding Author InformationReprint requests to David H. Abramson, MD, 70 East 66th Street, New York, NY 10021, USA.

 Manuscript no. 230151.

Supported in part by the Samuel and May Rudin Family Foundation, New York, New York.

The authors have no proprietary interest in products mentioned in the article.

PII: S0161-6420(03)01738-X

doi:10.1016/j.ophtha.2003.08.036


View previous. 9 of 42 View next.